Indications and limitations of afamelanotide for treating vitiligo-reply.
作者信息
Lim Henry W, Grimes Pearl E, Lebwohl Mark
机构信息
Multicultural Dermatology Center, Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
Vitiligo and Pigmentation Institute of Southern California, Los Angeles.
出版信息
JAMA Dermatol. 2015 Mar;151(3):350. doi: 10.1001/jamadermatol.2014.4951.
Abstract
摘要
相似文献
1
Indications and limitations of afamelanotide for treating vitiligo-reply.阿法美拉酮治疗白癜风的适应证与局限性——回复
JAMA Dermatol. 2015 Mar;151(3):350. doi: 10.1001/jamadermatol.2014.4951.
2
Indications and limitations of afamelanotide for treating vitiligo.阿法美拉酮治疗白癜风的适应症及局限性
JAMA Dermatol. 2015 Mar;151(3):349-50. doi: 10.1001/jamadermatol.2014.4848.
3
Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians.阿法美拉酮植入剂与窄谱中波紫外线光疗治疗亚洲人非节段性白癜风
J Am Acad Dermatol. 2020 Jun;82(6):1517-1519. doi: 10.1016/j.jaad.2020.01.035. Epub 2020 Jan 25.
4
The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.阿法诺肽和窄谱 UV-B 光疗治疗白癜风复色的疗效。
JAMA Dermatol. 2013 Jan;149(1):68-73. doi: 10.1001/2013.jamadermatol.386.
5
Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.阿法诺肽与窄谱中波紫外线光疗治疗白癜风：一项随机多中心试验。
JAMA Dermatol. 2015 Jan;151(1):42-50. doi: 10.1001/jamadermatol.2014.1875.
6
Medical and Maintenance Treatments for Vitiligo.白癜风的医学及维持治疗
Dermatol Clin. 2017 Apr;35(2):163-170. doi: 10.1016/j.det.2016.11.007.
7
Pseudocatalase and narrowband ultraviolet B for vitiligo: clearing the picture.
Br J Dermatol. 2009 Oct;161(4):721-2. doi: 10.1111/j.1365-2133.2009.09292.x.
8
UVA 1 laser in the treatment of patients with vitiligo.紫外线A1激光治疗白癜风患者
Dermatol Ther. 2017 Jul;30(4). doi: 10.1111/dth.12494. Epub 2017 Apr 20.
9
Relationship between α-melanocyte stimulating hormone levels and therapeutic outcome of melanocyte transplantation and phototherapy in non-segmental patients with vitiligo: A prospective study.
Australas J Dermatol. 2018 Nov;59(4):e315-e318. doi: 10.1111/ajd.12769. Epub 2018 Jan 10.
10
Jak-inhibitors and UV-B: Potential combined therapy for vitiligo.JAK抑制剂与紫外线B：白癜风的潜在联合治疗方法
Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12531. Epub 2017 Aug 18.
引用本文的文献
1
Emerging Therapeutic Innovations for Vitiligo Treatment.白癜风治疗的新兴治疗创新
Curr Issues Mol Biol. 2025 Mar 14;47(3):191. doi: 10.3390/cimb47030191.
2
Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity.近期对白癜风的临床和机制研究为细胞特异性自身免疫提供了新的治疗选择。
J Clin Invest. 2025 Jan 16;135(2):e185785. doi: 10.1172/JCI185785.
3
Up-and-Coming Drugs for the Treatment of Vitiligo.治疗白癜风的新兴药物
Ann Dermatol. 2024 Aug;36(4):197-208. doi: 10.5021/ad.24.038.
4
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.白癜风：从发病机制到治疗进展的最新研究进展。
Int J Mol Sci. 2023 Mar 3;24(5):4910. doi: 10.3390/ijms24054910.
5
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.阿法美拉肽的药代动力学和药效学及其在治疗皮肤病中的临床应用。
Clin Pharmacokinet. 2017 Aug;56(8):815-823. doi: 10.1007/s40262-016-0501-5.
Zotero 插件